Dengue virus (DENV) infection is recognized as a major public health problem; \>50 million persons are infected each year worldwide ([@R1]), and the incidence of severe, sometimes lethal, forms of the disease is increasing ([@R2]). Dengue viruses are mosquitoborne flaviviruses with a single-stranded, nonsegmented, positive-sense RNA genome ≈11 kb in length. Four antigenically distinct serotypes, DENV types 1 to 4, exist ([@R3]). Infection with any serotype can lead to disease, ranging from mild infection, dengue fever (a generally mild disease with complete recovery), to severe forms (dengue hemorrhagic fever and dengue shock syndrome). Molecular epidemiologic studies have investigated the possibility of a link between particular DENV genotypes or clusters and particular clinical forms of disease ([@R4]*,*[@R5]). Consequently, finding new viral genotypes in areas where they had been absent could be of epidemiologic and clinical interest. A recent work described the emergence and the global spread of DENV-3 subtype III ([@R5]). Originating from the Sri Lankan/Indian subcontinent, the new variant likely spread to eastern Africa in the 1980s, then to Latin America in the mid-1990s ([@R5]). Previous work in our laboratory identified a DENV-3 subtype 3 of the same origin in Martinique in 1999 ([@R6]).

Whereas other Caribbean islands had annual dengue epidemics, the last outbreak reported in Saint Martin (French West Indies) ([Figure 1](#F1){ref-type="fig"}) was in 1977 ([@R7]). Only DENV-1 was isolated during this epidemic, while DENV-1, DENV-2, and DENV-3 circulated in Puerto Rico at the same time ([@R8]). In 2000, during an interepidemic period, 1 isolate of DENV-3 was reported in Saint Martin (<http://www.carec.org/annrep00/index.html>), but to our knowledge its sequence was not determined. During the last 3 years, no further DENV isolates have been reported on the island. However, in December 2003, an outbreak of febrile illness was reported after heavy rains. An estimated 108 persons were infected, and DENV was suspected to be the causative agent by Saint Martin Lepers Laboratory ([@R9]). During this period, blood samples collected at early and late stages of infections were examined at the Tropical Medicine Institute of the French Armed Forces Medical Service (Institut de Médecine Tropicale du Service de Santé des Armées \[IMTSSA\]) tropical virology laboratory in Marseille to identify the etiologic agent. DENV-3 was isolated on C6/36 cells (*Aedes albopictus*). Partial genomic sequences were determined for each isolated virus to evaluate the origin and diversity of its spread. This approach should help clarify the geographic distribution of isolates in the Caribbean islands as well as the virus\' circulation in and transmission to humans.

![Map of Saint Martin, an island in the Caribbean. The lower map represents the Caribbean subregion. The year of dengue virus type 3 subtype III detection is indicated under the concerned island or country. The upper map is a close-up of Saint Martin. Source: Centre de documentation de l\'Institut de Médecine Tropicale du Service de Santé des Armées.](04-0959-F1){#F1}

Materials and Methods
=====================

The Outbreak
------------

In December 2003, an outbreak of febrile illness was reported ([@R9]) after heavy rainfalls in Saint Martin (29,000 inhabitants in the French part and 36,000 in the Dutch part). The outbreak seemed to start first in the northeastern part of the island (\"Baie orientale\" and \"Cul de sac\" neighborhoods), then spread through the island ([Figure 1](#F1){ref-type="fig"}). The temporal distribution of the outbreak is shown in [Figure 2](#F2){ref-type="fig"} ([@R10]). We used a commercial enzyme-linked immunosorbent assay (ELISA) (Eurobio, Courtaboeuf, France) in Saint Martin Lepers Laboratory to determine that, from October 2003 to April 2004, a total of 108 persons were infected; a DENV was suspected as the etiologic agent ([@R10]). Twelve persons manifesting thrombocytopenia without hemorrhagic signs were hospitalized ([@R9]).

![Temporal distribution of the outbreak (adapted from \[10\]). Bars indicate the suspected dengue patients observed by sentinel physicians; dark squares (curve) indicate laboratory-confirmed cases.](04-0959-F2){#F2}

Collection and Transport of Samples
-----------------------------------

Sera from 26 patients with dengue-like syndromes were collected at a local laboratory and transported (by air, at 4°C) to the IMTSSA laboratory in Marseille for serologic diagnosis and etiologic agent identification. All these samples were collected from December 2003 to January 2004, the peak of the outbreak.

Serologic Diagnosis
-------------------

In-house immunoglobulin (Ig) M-capture enzyme immunoassays (MAC-ELISA) and IgG sandwich ELISA were used to detect serum IgM and IgG antibodies to Toscana virus, dengue viruses, West Nile virus, and St. Louis encephalitis virus. Briefly, IgM antibodies were captured with rabbit anti-human IgM antibodies (Interchim, Montluçon, France). Toscana, dengue, West Nile, and Saint Louis antigens, prepared on Vero cells and inactivated by betapropiolactone (Sigma-Aldrich, St Quentin Fallavier, France), were added. Specific binding was demonstrated by using a Toscana virus, dengue viruses, West Nile virus, and St. Louis encephalitis virus mouse hyperimmune ascitic fluid virus ([@R11]) and a goat anti-mouse peroxidase-labeled conjugate (Interchim). For IgG detection, antibodies to Toscana virus, dengue viruses, West Nile virus, and St. Louis encephalitis virus were captured by goat anti-mouse IgG antibodies; viral antigens were followed by test sera; and specific binding was demonstrated by using a peroxidase-labeled goat anti-human IgG conjugate. Serum samples were considered positive if the optical density at 450 nm was \>3-fold the mean of negative sera with an OPTImax spectrophotometer (Molecular Devices, Saint Gregoire, France).

Virus Isolation and Propagation
-------------------------------

Work with the infectious virus was carried out in a biosafety level 3 laboratory. Virus isolation was attempted when the first sample could be collected \<5 days after onset of illness and when enough serum was collected for serologic analysis ([@R12]). DENV-3 strains ([Table A1](#TA.1){ref-type="table"}) were all isolated from leukocytes of patients. Leukocytes of the samples were directly coincubated with C6/36 cells (*Ae. albopictus*) grown at 28°C in Leibowitz\'s L15 medium (BioWhittaker Europe, Verniers, Belgium) supplemented with 1% L-glutamine and 2% tryptose phosphate broth. Fetal bovine serum (5% final) was added 1 h later. Supernatants were collected on day 5 after infection.

Indirect immunofluorescence (IF) was performed on C6/36 cells with DENV-1, -2, -3, and -4 serotype--specific monoclonal antibodies (kindly provided by Nick Karabatsos, Centers for Disease Control and Prevention, Fort Collins, Colorado); on mouse hyperimmune ascitic fluids for West Nile virus and Bunyamwera virus; and on grouping fluids for alphaviruses, phleboviruses, and California serogroup viruses. After isolation attempts, remaining sera were used for serologic studies but not for DENV-3--specific reverse transcription--polymerase chain reaction (RT-PCR) because too little serum was available after serologic tests.

RNA Preparation and cDNA Synthesis
----------------------------------

Viral RNA was extracted from 200-μL aliquots of infected cells supernatants by using the High Pure Viral RNA kit (Roche Diagnostics, Meylan, France) following manufacturer\'s protocol. Two overlapping viral cDNA fragments were generated by RT with Superscript II reverse transcriptase (Invitrogen/Life Technologies, Cergy Pontoise, France) according to the manufacturer protocols with D3/C/863/18 and D3/C/1419/18 primers (Table). Specific primers (Table) designed from the nucleotide sequence of the reference DENV-3 H87 (GenBank accession no. L11423) ([@R13]) were used for PCR amplification by using AmpliTaq DNA Gold (Applera, Courtaboeuf, France).

DNA Sequencing
--------------

PCR products were purified from 1.5 % agarose gels, by using the QIAquick gel extraction kit (Qiagen, Courtaboeuf, France) and directly sequenced with the direct and reverse primers (Table) and the Big Dye Sequencing kit (Applera). Sequencing was carried out with an automatic sequence analyzer (ABI PRISM 3100, Applera) following the manufacturer\'s protocol.

Sequences of the Saint Martin DENV isolates were compared to GenBank database DENV sequences ([Table A1](#TA.1){ref-type="table"}). Alignments of nucleotide and amino acid sequences of the prM/M and partial E nucleotide sequences (nucleotide numbers 437--1144 by reference to the sequence of the D3H87 strain) were performed with ClustalW1.7 software ([@R14]). Phylograms were constructed with the MEGA 2 program ([@R15]), and tree drawing used the Jukes-Cantor algorithm for genetic distance determination and the Neighbor Joining method. The robustness of the resulting tree was tested by 1,000 bootstrap replications.

Results and Discussion
======================

From October 2003 to April 2004, DENV-3 circulated on the island, and 108 cases of dengue fever were serologically or virologically confirmed in both the Lepers Laboratory and the IMTSSA laboratory, and 12 persons were hospitalized ([@R10]). If one takes into account the 180 suspected cases observed during this period, the incidence of dengue fever during the epidemic was ≈0.62% (180/29,000) on the French part of the island; this value was consistent with values already observed in the Caribbean region (<http://www.carec.org/data/dengue/1998/table2.html>). No data were available from the Dutch half.

During this period, an additional 26 blood samples from patients with dengue-like syndromes at early stage of the infection were received in IMTSSA Tropical Virology Laboratory in Marseille. Among them, 13 were positive for dengue infection by presence of IgM, elevation (4-fold) of specific IgG, or both. Virus was isolated from 6 other patients, and DENV-3 was identified by IF using serotype-specific monoclonal antibodies. No fluorescence was observed when DENV-1, DENV-2, or DENV-4 monoclonal antibodies were used. Moreover, IF tests were negative when antibody to West Nile virus, Toscana virus, Bunyamwera virus, alphaviruses, phleboviruses and California serogroup viruses was used. These cases were considered confirmed dengue fever; all the patients recovered fully.

DENV-3 was genetically identified in the 6 IF positive isolates (D3StMart1--D3StMart6, referred to as GenBank accession no. AY750713--AY750718) by using BLAST-NCBI software. Comparison of partial sequences showed a high degree of identity between the strains isolated from patients on Saint Martin: paired identity at the nucleotide level ranged from 99.3% to 100%. When compared to 00PuertoR1 strain of the Latin American cluster defined by Messer ([@R5]), the values were 99.5%--99.6%. Nucleotide comparison gave the following values: 98.3%--98.4% for East African cluster ([@R5]), 98.8%--98.9% for Group B ([@R5]), and 96.8%--96.9% for Group A ([@R5]). This comparison indicated a close relationship between Saint Martin and Latin American isolates.

The strains from Saint Martin shared an 11-nucleotide insertion between position 10,275 and position 10,276 in the 3´UTR (AGTGAAAAAGA). The same insertion was found in isolates from Martinique 2 years earlier ([@R6]) and from DENV-3 Sri Lanka ([@R6]), indicating a probable common ancestor. This finding was consistent with a Sri Lankan origin for DENV-3 subtype III circulating in the Latin American and Caribbean regions ([@R5]) and with extension of the virus from a single importation event.

A phylogenetic tree was constructed based on partial sequences of the prM/M-E gene region (position 437--1144) of the genomes, including the strains from Saint Martin and several other previously characterized strains from different origins ([@R16]*--*[@R19]). DENV isolated from Saint Martin was grouped in subtype III, as defined by Lanciotti ([@R17]) (data not shown). Another phylogenetic tree was constructed with the strains analyzed by Messer ([@R5]) ([Figure 3](#F3){ref-type="fig"}). Despite the high overall similarity of the subtype III sequences, distinct groups could be distinguished. The 6 isolates from Saint Martin clustered together. The small lineage difference of D3StMart2 is supported by a 95-bootstrap value, but no evidence suggests that such difference implies multiple introductions or a longer transmission period. However, Saint Martin DENV-3 fell in the Latin American cluster defined by Messer ([@R5]), which also includes isolates from Guatemala, Nicaragua, and Mexico. Isolates from Saint Martin were particularly close to Martinique isolates ([@R6]) and the 00PuertoR1 isolate, which were the geographically and temporally closest isolates of the cluster. The analysis of the deduced amino acid sequences generated a similar phylogram. Altogether, these results indicate that the Saint Martin viral isolate belongs to the genotype Puerto Rico 2000 previously reported ([@R5]). These results also confirm a common origin for all DENV-3 circulating in the Caribbean and Latin American region; their ancestor probably originated from Sri Lanka. Additional American DENV-3 strain sequences, encompassing the insertion site, should help to confirm this hypothesis.

![Phylogenetic tree of dengue type 3 subtype III viruses, based on prM/M and partial E nucleotide sequences (nucleotide numbers 437 to 1144) available in GenBank database. Phylograms were constructed with the MEGA 2 program (15), using the Jukes-Cantor algorithm and the neighbor joining method. The percentage of successful bootstrap replicates (1,000 bootstrap replications, confidence probability \>90%) is indicated at nodes. The length of branches is proportional to the number of nucleotide changes (percentage of divergence). The strains sequenced in this work are underlined. Dark triangles correspond to viruses of the same group clustering together; dots indicate a change in scale.](04-0959-F3){#F3}

The question arose whether the introduction from Sri Lanka was a single event in the Latin American region, first appearing in Panama ([@R5]), then spreading through the Caribbean subregion and South America. In fact, viruses belonging to subtype III were first reported in Nicaragua and Panama in 1994 ([@R20]). They were then identified in Guatemala from 1996 to 1998; in Puerto Rico, Barbados, and Jamaica in 1998 ([@R18]); and in Martinique in 1999 ([@R6]). The introduction of DENV-3 in Saint Martin was reported in 2000 (<http://www.carec.org/annrep00/index.html>), but the subtype was not determined. No virus isolation was reported for 3 years, until the viruses we characterized were isolated. The rapid extension of DENV-3 belonging to subtype III, which have almost completely replaced preexisting DENV of serotype 1 and 2, is indicative that these particular viruses have adapted to Caribbean and Latin American conditions. Together with previous studies ([@R5]*,*[@R6]), identification of viruses belonging to subtype III in another area of the Caribbean region confirms the remarkable epidemiologic success of this particular lineage of dengue viruses.

Comparable substitution of local DENV by a new genotype was previously described in the Caribbean region ([@R12]). New viruses, often originating from Southeast Asia, arise as successive waves, replacing previous ones. In this regard, sampling of DENV-3 subtype III virus nucleotide sequences from all countries in the Caribbean and the peri-Caribbean area need to be expanded so that we can understand DENV circulation in the region.
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###### DENV-3 sequences and corresponding GenBank accession numbers\*

  Name            Location              Source       Date         Accession no.          Subtype   Group
  --------------- --------------------- ------------ ------------ ---------------------- --------- ---------------
  D3StMart1       Saint Martin island   This study   Dec. 2003    AY750713               III       Latin America
  D3StMart2       Saint Martin island   This study   Dec. 2003    AY750714               III       Latin America
  D3StMart3       Saint Martin island   This study   Jan. 2004    AY750715               III       Latin America
  D3StMart4       Saint Martin island   This study   Jan. 2004    AY750716               III       Latin America
  D3StMart5       Saint Martin island   This study   Jan. 2004    AY750717               III       Latin America
  D3StMart6       Saint Martin island   This study   Jan. 2004    AY750718               III       Latin America
  D3Mart2336      Martinique island     GenBank      Jan. 2001    AY099342               III       Latin America
  98Nicara1       Nicaragua             GenBank      1998         AF547245               III       Latin America
  98Nicara2       Nicaragua             GenBank      1998         AF547246               III       Latin America
  98Nicara3       Nicaragua             GenBank      1998         AF547262               III       Latin America
  94Panama1       Panama                GenBank      1994         AF547247               III       Latin America
  94Panama2       Panama                GenBank      1994         AF547248               III       Latin America
  94Panama3       Panama                GenBank      1994         AF547249               III       Latin America
  96Mexico1       Mexico                GenBank      1996         AF547250               III       Latin America
  96Mexico2       Mexico                GenBank      1996         AF547251               III       Latin America
  96Mexico3       Mexico                GenBank      1996         AF547252               III       Latin America
  96Mexico4       Mexico                GenBank      1996         AF547253               III       Latin America
  95CostaR1       Costa Rica            GenBank      1995         AF547254               III       Latin America
  95CostaR2       Costa Rica            GenBank      1995         AF547255               III       Latin America
  95CostaR3       Costa Rica            GenBank      1995         AF547256               III       Latin America
  95CostaR4       Costa Rica            GenBank      1995         AF547257               III       Latin America
  97Guatem1       Guatemala             GenBank      1997         AF547263               III       Latin America
  98PuertoR1      Puerto Rico           GenBank      1998         AF547258               III       Latin America
  00PuertoR1      Puerto Rico           GenBank      2000         AF547264               III       Latin America
  98ElSalv1       El Salvador           GenBank      1998         AF547259               III       Latin America
  01VEN03         Venezuela             GenBank      2001         AF547261               III       Latin America
  93SriLan1       Sri Lanka             GenBank      1993         AF547234               III       unclassified
  D3SriLa1266     Sri Lanka             GenBank      2000         AY099336               III       unclassified
  83SriLan1       Sri Lanka             GenBank      1983         AF547225               III       Group A
  83SriLan2       Sri Lanka             GenBank      1983         AF547226               III       Group A
  83SriLan3       Sri Lanka             GenBank      1983         AF547227               III       Group A
  83SriLan4       Sri Lanka             GenBank      1983         AF547228               III       Group A
  84SriLan1       Sri Lanka             GenBank      1984         AF547229               III       Group A
  85SriLan        Sri Lanka             GenBank      1985         AF547241               III       Group A
  89SriLan2       Sri Lanka             GenBank      1989         AF547231               III       Group A
  89SriLan1       Sri Lanka             GenBank      1989         AF547230               III       Group B
  89SriLan3       Sri Lanka             GenBank      1989         AF547232               III       Group B
  90SriLan1       Sri Lanka             GenBank      1990         AF547233               III       Group B
  94SriLan1       Sri Lanka             GenBank      1994         AF547235               III       Group B
  97SriLan1       Sri Lanka             GenBank      1997         AF547242               III       Group B
  81-91SriLanA    Sri Lanka             GenBank      1981,1991    L11431,L11436-L11438   III       Group B
  85Mozamb1       Mozambique            GenBank      1985         AF547236               III       East Africa
  85Mozamb2       Mozambique            GenBank      1985         AF547237               III       East Africa
  85Mozamb3       Mozambique            GenBank      1985         AF547238               III       East Africa
  91Kenya         Kenya                 GenBank      1991         AF547239               III       East Africa
  93Somalia       Somalia               GenBank      1993         AF547240               III       East Africa
  73-86Thailand   Thailand              GenBank      1973, 1986   L11441-L11442,L11620   II        reference
  83Philipp       Philippines           GenBank      1983         L11432                 I         reference
  89Tahiti        Tahiti                GenBank      1989         L111619                I         reference
  92Fiji          Fiji                  GenBank      1992         L11422                 I         reference
  73-85Indones    Indonesia             GenBank      1973, 1985   L11425,L11426,L11428   I         reference
  74,81Malaysi    Malaysia              GenBank      1974, 1981   L11429, L11427         I         reference
  D3H-87          Philippines           GenBank      1956         L11423                 I         reference
  63,77PuertoR    Puerto Rico           GenBank      1963,77      L11433, L11434         IV        reference
  65Tahiti        Tahiti                GenBank      1965         L11439                 IV        reference

###### Primers used for DENV-3 genome amplification and sequencing\*

  Primer name     (5´→ 3´) Sequence    Genome position†
  --------------- -------------------- ------------------
  D3/D/1/17       AGTTGTTAGTCTACGTG    1--17
  D3/D/740/18     GGACTGGACACACGCACT   740--757
  D3/D/9970/18    GTGGATGACTACAGAAGA   9970--9987
  D3/C/863/18     AATGGGCAAGAAATAGGG   863--846
  D3/C/1419/18    ATCTCAGCCGTAACTCCC   1419--1402
  D3/C/10696/18   AGAACCTGTTGATTCAAC   10696--10679

\*DENV, dengue virus. †According to the DENV-3 H87 reference sequence.
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